Venzon D - Search Results

1

In vivo radiation protection by nitric oxide modulation.

Liebmann J, DeLuca AM, Coffin D, Keefer LK, Venzon D, Wink DA, Mitchell JB. Liebmann J, et al. Among authors: venzon d. Cancer Res. 1994 Jul 1;54(13):3365-8. Cancer Res. 1994. PMID: 7516820

2

Identification of nitroxide radioprotectors.

Hahn SM, Wilson L, Krishna CM, Liebmann J, DeGraff W, Gamson J, Samuni A, Venzon D, Mitchell JB. Hahn SM, et al. Among authors: venzon d. Radiat Res. 1992 Oct;132(1):87-93. Radiat Res. 1992. PMID: 1410280

3

HLA association with response and toxicity in melanoma patients treated with interleukin 2-based immunotherapy.

Marincola FM, Venzon D, White D, Rubin JT, Lotze MT, Simonis TB, Balkissoon J, Rosenberg SA, Parkinson DR. Marincola FM, et al. Among authors: venzon d. Cancer Res. 1992 Dec 1;52(23):6561-6. Cancer Res. 1992. PMID: 1423301

4

Tempol, a stable free radical, is a novel murine radiation protector.

Hahn SM, Tochner Z, Krishna CM, Glass J, Wilson L, Samuni A, Sprague M, Venzon D, Glatstein E, Mitchell JB, et al. Hahn SM, et al. Among authors: venzon d. Cancer Res. 1992 Apr 1;52(7):1750-3. Cancer Res. 1992. PMID: 1551104

5

Prolonged survival of tumor-bearing rats with repetitive low-dose recombinant tumor necrosis factor.

Sheppard BC, Venzon D, Fraker DL, Langstein HN, Jensen JC, Norton JA. Sheppard BC, et al. Among authors: venzon d. Cancer Res. 1990 Jul 1;50(13):3928-33. Cancer Res. 1990. PMID: 2354441

6

Lack of in vitro synergy between etoposide and cis-diamminedichloroplatinum(II).

Tsai CM, Gazdar AF, Venzon DJ, Steinberg SM, Dedrick RL, Mulshine JL, Kramer BS. Tsai CM, et al. Among authors: venzon dj. Cancer Res. 1989 May 1;49(9):2390-7. Cancer Res. 1989. PMID: 2706626

7

Taxol in combination with doxorubicin or etoposide. Possible antagonism in vitro.

Hahn SM, Liebmann JE, Cook J, Fisher J, Goldspiel B, Venzon D, Mitchell JB, Kaufman D. Hahn SM, et al. Among authors: venzon d. Cancer. 1993 Nov 1;72(9):2705-11. doi: 10.1002/1097-0142(19931101)72:9<2705::aid-cncr2820720930>3.0.co;2-k. Cancer. 1993. PMID: 8104682

8

A phase I and pharmacokinetic study of intravenous phenylacetate in patients with cancer.

Thibault A, Cooper MR, Figg WD, Venzon DJ, Sartor AO, Tompkins AC, Weinberger MS, Headlee DJ, McCall NA, Samid D, et al. Thibault A, et al. Among authors: venzon dj. Cancer Res. 1994 Apr 1;54(7):1690-4. Cancer Res. 1994. PMID: 8137283 Clinical Trial.

9

A phase II study of continuous infusion 5-fluorouracil and leucovorin with weekly cisplatin in metastatic colorectal carcinoma.

Grem JL, McAtee N, Balis F, Murphy R, Venzon D, Kramer B, Goldspiel B, Begley M, Allegra CJ. Grem JL, et al. Among authors: venzon d. Cancer. 1993 Aug 1;72(3):663-8. doi: 10.1002/1097-0142(19930801)72:3<663::aid-cncr2820720307>3.0.co;2-v. Cancer. 1993. PMID: 8334622 Clinical Trial.

10

Evaluation of tempol radioprotection in a murine tumor model.

Hahn SM, Sullivan FJ, DeLuca AM, Krishna CM, Wersto N, Venzon D, Russo A, Mitchell JB. Hahn SM, et al. Among authors: venzon d. Free Radic Biol Med. 1997;22(7):1211-6. doi: 10.1016/s0891-5849(96)00556-4. Free Radic Biol Med. 1997. PMID: 9098095 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

435 results

Search Page

Filters